Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder.

Depression has been associated with various cardiovascular risk factors such as hypertension, obesity, atherogenic dyslipidemia and hyperglycemia. In depressive disorder, hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and changes in the immune system have been observed. On the other hand, somatic diseases such as obesity, hyperlipidemia, hypertension and diabetes mellitus type 2 are now perceived as important comorbid conditions in patients with depression. The pathogenesis of the metabolic syndrome and depression is complex and poorly researched; however, it is considered that the interaction of chronic stress, psychotrauma, hypercotisolism and disturbed immune functions contribute to the development of these disorders. The aim of the study was to investigate the relationship between depression and metabolic syndrome regarding the HPA axis dysfunction and altered inflammatory processes. Literature search in Medline and other databases included articles written in English published between 1985 and 2012. Analysis of the literature was conducted using a systematic approach with the search terms such as depression, metabolic syndrome, inflammation, cytokines, glucocorticoids, cortisol, and HPA axis. In conclusion, the relationship between depression and metabolic syndrome is still a subject of controversy. Further prospective studies are required to clarify the possible causal relationship between depression and metabolic syndrome and its components. Furthermore, it is important to explore the possibility of a common biologic mechanism in the pathogenesis of these two disorders, in which special attention should be paid to the immune system function, especially the possible specific mechanisms by which cytokines can induce and maintain depressive symptoms and metabolic disorders. The data presented here emphasize the importance of recognition and treatment of depressive disorders with consequent reduction in the incidence of metabolic syndrome, but also the need of regular search for metabolic disorders and their treatment to avoid all of these adverse effects and maybe reduce the incidence of depressive disorders.

• Publication year

  2014

• Venue

  Acta Clinica Croatica

• Publication date

  2014-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 24974667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin Resistance in Type 2 Diabetes

  2016cited by this paper
• Pathogenesis of Type 2 Diabetes Mellitus

  2015cited by this paper
• [Obesity and metabolic syndrome in children and adolescents].

  2013cited by this paper
• Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.

  2012cited by this paper
• Connection between inflammatory markers, antidepressants and depression.

  2012cited by this paper
• Immunological Aetiology of Major Psychiatric Disorders

  2012cited by this paper
• A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

  2009cited by this paper
• Association of metabolic syndrome with depression and anxiety in Japanese men.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being.

  2008cited by this paper
• Identification and treatment of symptoms associated with inflammation in medically ill patients.

  2008cited by this paper
• The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior

  2008cited by this paper
• Inflammation, Glutamate, and Glia in Depression: A Literature Review

  2008cited by this paper
• Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study.

  2008cited by this paper
• From inflammation to sickness and depression: when the immune system subjugates the brain

  2008cited by this paper
• Metabolic Syndrome Pandemic

  2008cited by this paper
• Depressive symptoms and metabolic syndrome: is inflammation the underlying link?

  2008cited by this paper
• Cytokine imbalance in the pathophysiology of major depressive disorder.

  2007cited by this paper
• The Anticonvulsants Lamotrigine, Riluzole, and Valproate Differentially Regulate AMPA Receptor Membrane Localization: Relationship to Clinical Effects in Mood Disorders

  2007cited by this paper
• Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.

  2007cited by this paper
• Chronic immune activation underlies morbid obesity: is IDO a key player?

  2007cited by this paper
• A review of the metabolic syndrome.

  2007cited by this paper
• Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature

  2007cited by this paper
• Depressive Symptoms and Stressful Life Events Predict Metabolic Syndrome Among Middle-Aged Women

  2007cited by this paper
• The challenges of first-episode psychosis in the light of the brave new (postmodern) psychiatry.

  2007cited by this paper
• Role of interleukin‐6 signalling in glucose and lipid metabolism

  2007cited by this paper
• Obesity, Metabolic Syndrome, and Cardiovascular Disease

  2007cited by this paper
• Tumour necrosis factor‐α in human adipose tissue – from signalling mechanisms to clinical implications

  2007cited by this paper
• Associations between anxiety, depression, and the metabolic syndrome.

  2007cited by this paper
• Cerebrospinal fluid IL-6, HSP72, and TNF-alpha in exercising humans.

  2006cited by this paper
• Metabolic syndrome and depression: a cross-sectional analysis.

  2006cited by this paper
• Cytokines sing the blues: inflammation and the pathogenesis of depression.

  2006cited by this paper
• Associations between depressive symptoms and insulin resistance: The Hoorn Study

  2006cited by this paper
• Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up.

  2006cited by this paper
• Co-occurrence of Metabolic Syndrome With Depression and Anxiety in Young Adults: The Northern Finland 1966 Birth Cohort Study

  2006cited by this paper
• Cerebrospinal fluid IL-6, HSP72, and TNF-α in exercising humans

  2006cited by this paper
• Cytokines, p38 MAP Kinase and the Pathophysiology of Depression

  2006cited by this paper
• Depression and cardiovascular disease: healing the broken-hearted.

  2006cited by this paper
• The metabolic syndrome and concentrations of C-reactive protein among U.S. youth.

  2005cited by this paper
• Metabolic syndrome.

  2005cited by this paper
• History of depression increases risk of type 2 diabetes in younger adults.

  2005cited by this paper
• Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME)

  2005cited by this paper
• Our passive lifestyle, our toxic diet, and the atherogenic/diabetogenic metabolic syndrome: can we afford to be sedentary and unfit?

  2005cited by this paper
• Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome

  2005cited by this paper
• A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.

  2005cited by this paper
• Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in young adults: the amsterdam growth and health longitudinal study.

  2005cited by this paper
• Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife.

  2005cited by this paper
• Role of stress in the pathogenesis of the metabolic syndrome.

  2005cited by this paper
• Proinflammatory Cytokines: A Common Denominator in Depression and Somatic Symptoms?

  2005cited by this paper
• Fatty acids and insulin resistance in muscle and liver.

  2005cited by this paper
• The evolving role of inflammation in obesity and the metabolic syndrome

  2005cited by this paper
• The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.

  2005cited by this paper
• Cytokines and major depression.

  2005cited by this paper
• The metabolic syndrome : a chronic cardiovascular inflammatory condition

  2005cited by this paper
• Overproduction of VLDL1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia

  2005cited by this paper
• Insulin resistance and the endothelium

  2005cited by this paper
• Metabolic syndrome: a clinical and molecular perspective.

  2005cited by this paper
• Insulin resistance in type 2 diabetes -- role of the adipokines.

  2005cited by this paper
• Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

  2005cited by this paper
• Development of Fatness, Fitness, and Lifestyle From Adolescence to the Age of 36 Years: Determinants of the Metabolic Syndrome in Young Adults: The Amsterdam Growth and Health Longitudinal Study

  2005cited by this paper
• Association of depression with medical illness: does cortisol play a role?

  2004cited by this paper
• Cytokines: abnormalities in major depression and implications for pharmacological treatment

  2004cited by this paper
• Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study.

  2004cited by this paper
• The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes.

  2004cited by this paper
• CRSN Symposium : Focus on Depression , Part I Symposium du CRSN : le point sur la dépression , première partie Implication of the hypothalamic – pituitary – adrenal axis in the physiopathology of depression

  2004cited by this paper
• The metabolic syndrome.

  2004cited by this paper
• Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.

  2004cited by this paper
• Pathogenesis of type 2 diabetes mellitus.

  2004cited by this paper
• Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).

  2004cited by this paper
• Cytokines and psychopathology: lessons from interferon-alpha.

  2004cited by this paper
• Insulin resistance and depression: cross sectional study

  2004cited by this paper
• Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

  2004cited by this paper
• Depression and the Metabolic Syndrome in Young Adults: Findings From the Third National Health and Nutrition Examination Survey

  2004cited by this paper
• Obesity and the metabolic syndrome in children and adolescents.

  2004cited by this paper
• Diabetic dyslipidaemia: from basic research to clinical practice*

  2003cited by this paper
• Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

  2003cited by this paper
• Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.

  2003cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• Prospective association between obesity and depression: evidence from the Alameda County Study

  2003cited by this paper
• Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

  2003cited by this paper
• Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.

  2003cited by this paper
• Depressive Symptoms and Metabolic Risk in Adult Male Twins Enrolled in the National Heart, Lung, and Blood Institute Twin Study

  2003cited by this paper
• Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects.

  2003cited by this paper
• Obesity is associated with macrophage accumulation in adipose tissue.

  2003cited by this paper
• Obesity-induced inflammatory changes in adipose tissue.

  2003cited by this paper
• Cytokines, stress, and depressive illness.

  2002cited by this paper
• Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.

  2002cited by this paper
• Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

  2002cited by this paper
• Obesity, metabolic syndrome, and coronary atherosclerosis.

  2002cited by this paper
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Long-Term Survival Differences Among Low-Anxious, High-Anxious and Repressive Copers Enrolled in the Montreal Heart Attack Readjustment Trial

  2002cited by this paper
• Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study

  2002cited by this paper
• A Path Model of Chronic Stress, the Metabolic Syndrome, and Coronary Heart Disease

  2002cited by this paper
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

  2002cited by this paper
• Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

  2002cited by this paper
• Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.

  2002cited by this paper
• The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence?

  2002cited by this paper
• Epidemiologic evidence on the comorbidity of depression and diabetes.

  2002cited by this paper
• Are depressive symptoms a risk factor for mortality in elderly Japanese American men?: the Honolulu-Asia Aging Study.

  2002cited by this paper
• The prevalence of comorbid depression in adults with diabetes: a meta-analysis.

  2001cited by this paper

• The Impact of Metabolic Comorbidities (Diabetes, Hypertension) on the Severity and Progression of Oropharyngeal Infections

  2026cites this paper
• Effect of non-pharmacological interventions on depression in obese individuals: a network meta-analysis.

  2026cites this paper
• Efficacy of probiotic adjuvant therapy in women with major depressive disorder: insights from a case series study

  2025cites this paper
• Melatonin modulation of the chronic dexamethasone-induced adrenal insufficiency

  2025cites this paper
• Bidirectional causal relationship between depression and Type 2 diabetes: a multi-ancestry and sex stratified Mendelian Randomization analysis.

  2025cites this paper
• Prevalence and Risk Factors of Comorbid Type 2 Diabetes Mellitus in Adults With Severe Mental Disorders: A Retrospective Study

  2025cites this paper
• Antidepressive and cardioprotective effects of Kai-xin-san via the regulation of HPA axis dysfunction and lipid metabolism in a rat model of depressive-cardiac disease.

  2024cites this paper
• Androgens Suppress Corticosteroid Binding Globulin in Male Mice, Affecting the Endocrine Stress Response

  2024cites this paper
• Effectiveness of Mindfulness-Based Cognitive Therapy on Depressive Symptoms, Brain Potential, and Neuroimmunoinflammatory Factors in Depressed Patients

  2024cites this paper
• Depression and type 2 diabetes: A causal relationship and mechanistic pathway

  2024cites this paper
• Association between major depressive disorder or depressive symptoms and the risk of vascular complications among patients with type 2 diabetes, and the mediating role of metabolic biomarkers: an analysis of the UK Biobank cohort

  2024cites this paper
• Evaluating Facilitators’ Experience Delivering a Stress-Reducing Intervention for Indigenous Women with and without HIV

  2023cites this paper
• From biological aging to functional decline: A narrative review of insights into chronic inflammation and intrinsic capacity.

  2023cites this paper
• Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder

  2023cites this paper
• The impact of a stress management intervention including cultural components on stress biomarker levels and mental health indicators among indigenous women

  2023cites this paper
• Antidepressants and type 2 diabetes: highways to knowns and unknowns

  2023cites this paper
• Risk factors for depression in asthmatic individuals: Findings from NHANES (2005–2018)

  2023cites this paper
• Effect of chronic unpredicted mild stress-induced depression on clopidogrel pharmacokinetics in rats

  2022cites this paper
• The Relationship Between Obesity and Depression Is Partly Dependent on Metabolic Health Status: A Nationwide Inpatient Sample Database Study

  2022cites this paper
• Neutrophil to lymphocyte ratio is a transdiagnostic biomarker of depression and structural and functional brain alterations in older adults.

  2022cites this paper
• Xiaoyao San, a Chinese herbal formula, ameliorates depression-like behavior in mice through the AdipoR1/AMPK/ACC pathway in hypothalamus.

  2022cites this paper
• Predictors of HRQOL among U.S. Hispanic Population with Hyperlipidemia and Co-Morbidities: A Race-Based Study

  2021cites this paper
• Elucidating the Possible Role of FoxO in Depression

  2021cites this paper
• Action Mechanism of Rosella (Hibiscus sabdariffa L.) Used to Treat Metabolic Syndrome in Elderly Women

  2020cites this paper
• Metabolic Syndrome in Bipolar Disorder

  2020cites this paper
• Role of glucocorticoid receptor phosphorylation-mediated synaptic plasticity in anxiogenic and depressive behaviors induced by monosodium glutamate

  2020cites this paper
• Association of Obesity with Depressive Symptomatology, Eating Habits, Interleukin-8 and Cortisol in a Young Population

  2020cites this paper
• Food & mood: a review of supplementary prebiotic and probiotic interventions in the treatment of anxiety and depression in adults

  2020cites this paper
• The Twenty-Year Rise of Psychiatric Science in Mostar.

  2020cites this paper
• Cohort study on the effects of depression on atherosclerotic cardiovascular disease risk in Korea

  2019cites this paper
• Neurocognitive impairment in type 2 diabetes mellitus

  2019cites this paper
• Obesogenic Behaviors and Depressive Symptoms' Influence on Cardiometabolic Risk Factors in American Indian Children.

  2019cites this paper
• DETERMINATION OF THE EFFECTS OF DAILY LIFE ACTIVITIES AND SELF-CARE CAPACITY ON DEPRESSION OF THE ELDERLY IN NORTHERN TURKEY

  2019cites this paper
• The depressed heart

  2019cites this paper
• Metabolic syndrome, depression and anhedonia among young adults.

  2019cites this paper
• Cardiovascular Risk Estimated by UKPDS Risk Engine Algorithm in Diabetes

  2018cites this paper
• Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress

  2018cites this paper
• Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders

  2018cites this paper
• Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study

  2018cites this paper
• Nrf2 Signaling Pathway Mediates the Antioxidative Effects of Taurine Against Corticosterone-Induced Cell Death in HUMAN SK-N-SH Cells

  2018cites this paper
• High expression of hippocampal glutamic acid decarboxylase 67 mediates hypersensitivity of the hypothalamic-pituitary-adrenal axis in response to prenatal caffeine exposure in rats.

  2018cites this paper
• Effects of a psychological intervention programme on mental stress, coping style and immune function in percutaneous coronary intervention patients

  2018cites this paper
• Long-term exposure to transportation noise in relation to metabolic and cardiovascular outcomes

  2018cites this paper
• Cardiovascular Risk Assessed by Reynolds Risk Score in Relation to Waist Circumference in Apparently Healthy Middle-Aged Population in Montenegro

  2018cites this paper
• BIOLOGICAL MECHANISMS RELATED TO CARDIOVASCULAR AND METABOLIC EFFECTS BY ENVIRONMENTAL NOISE

  2018cites this paper
• Retinol-binding protein 4 and hyperinsulinemia: The link between obesity and cardiovascular disease

  2017cites this paper
• Risk of depression in patients with uterine leiomyoma: A nationwide population-based cohort study.

  2017cites this paper
• Hyperlipidemia and statins use for the risk of new-onset anxiety/depression in patients with head and neck cancer: A population-based study

  2017cites this paper
• SILAC Mass Spectrometry Profiling: A Psychiatric Disorder Perspective.

  2017cites this paper
• Croatia ACTIVITY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND INFLAMMATORY MEDIATORS IN MAJOR DEPRESSIVE DISORDER WITH OR WITHOUT METABOLIC SYNDROME

  2017cites this paper
• Microglial Function during Glucose Deprivation: Inflammatory and Neuropsychiatric Implications

  2017cites this paper
• The Association Between Retinol-Binding Protein 4 and Cardiovascular Risk Score is Mediated by Waist Circumference in Overweight/Obese Adolescent Girls

  2017cites this paper
• Vitamin D Supplementation Affects the Beck Depression Inventory , Insulin Resistance , and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder : A Randomized , Controlled Clinical Trial 1 , 2

  2016cites this paper
• Biological rhythms, metabolic syndrome and current depressive episode in a community sample.

  2016cites this paper
• Depression-Like Adult Behaviors may be a Long-Term Result of Experimental Pneumococcal Meningitis in Wistar Rats Infants

  2016cites this paper
• Association between depression, parameters of adiposity and genetic polymorphisms of pro-inflammatory cytokines: IL-1α, IL-1β, IL-2 and IL-6 in subjects over 55 years old.

  2016cites this paper
• Sertraline inhibits increases in body fat and carbohydrate dysregulation in adult female cynomolgus monkeys.

  2016cites this paper
• Gestational Diabetes Mellitus and Mental Illness in Alberta

  2016cites this paper
• Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary

  2016cites this paper
• Depression Associated with Diabetes: From Pathophysiology to Treatment.

  2016cites this paper
• Disrupted Circadian Rhythm as a Common Player in Developmental Models of Neuropsychiatric Disorders.

  2016cites this paper
• Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial.

  2016cites this paper
• Age-related hypoxia in CNS pathology.

  2016cites this paper
• Early Life Stress Increases Metabolic Risk, HPA Axis Reactivity, and Depressive-Like Behavior When Combined with Postweaning Social Isolation in Rats

  2016cites this paper
• Clinical Scenario of the Metabolic Syndrome

  2016cites this paper
• ERK-dependent brain-derived neurotrophic factor regulation by hesperidin in mice exposed to chronic mild stress.

  2016cites this paper
• Incidence of Cardiovascular Risk Factors in Obese Children

  2016cites this paper
• Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder: A Randomized, Controlled Clinical Trial.

  2016cites this paper
• Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment.

  2015cites this paper
• Fish oil supplementation alleviates depressant-like behaviors and modulates lipid profiles in rats exposed to chronic unpredictable mild stress

  2015cites this paper
• Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models

  2015cites this paper
• A systematic review for the antidepressant effects of sleep deprivation with repetitive transcranial magnetic stimulation

  2015cites this paper
• The Impact of Abnormal Glucose Tolerance and Obesity on Fetal Growth

  2015cites this paper
• Interferon alpha-induced changes in emotional and nociceptive processing: involvement of the endocannabinoid system

  2015cites this paper
• Interaction of metabolic stress with chronic mild stress in altering brain cytokines and sucrose preference.

  2015cites this paper
• [Affective disorders: endocrine and metabolic comorbidities].

  2014cites this paper
• SVEUČILIŠTE U ZAGREBU MEDICINSKI FAKULTET SVEUČILIŠNI DIPLOMSKI STUDIJ SESTRINSTVA

  2014cites this paper
• The Role of Brain-Derived Neurotrophic Factor in Comorbid Depression: Possible Linkage with Steroid Hormones, Cytokines, and Nutrition

  2014cites this paper
• Understanding the Genetic and Environmental Contributions to Depression

  year unknowncites this paper